Cargando…
Diagnostic Blood Biomarkers in Alzheimer’s Disease
Potential biomarkers for Alzheimer’s disease (AD) include amyloid β(1–42) (Aβ(1–42)), t-Tau, p-Tau(181), neurofilament light chain (NFL), and neuroimaging biomarkers. Their combined use is useful for diagnosing and monitoring the progress of AD. Therefore, further development of a combination of the...
Autores principales: | Park, Jung Eun, Gunasekaran, Tamil Iniyan, Cho, Yeong Hee, Choi, Seong-Min, Song, Min-Kyung, Cho, Soo Hyun, Kim, Jahae, Song, Ho-Chun, Choi, Kyu Yeong, Lee, Jang Jae, Park, Zee-Yong, Song, Woo Keun, Jeong, Han-Seong, Lee, Kun Ho, Lee, Jung Sup, Kim, Byeong C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773964/ https://www.ncbi.nlm.nih.gov/pubmed/35052848 http://dx.doi.org/10.3390/biomedicines10010169 |
Ejemplares similares
-
Cerebrospinal Fluid Biomarkers for the Diagnosis of Prodromal Alzheimer's Disease in Amnestic Mild Cognitive Impairment
por: Park, Jung Eun, et al.
Publicado: (2019) -
Plasma contact factors as novel biomarkers for diagnosing Alzheimer’s disease
por: Park, Jung Eun, et al.
Publicado: (2021) -
Potential Novel Genes for Late-Onset Alzheimer’s Disease in East-Asian Descent Identified by APOE-Stratified Genome-Wide Association Study
por: Kang, Sarang, et al.
Publicado: (2021) -
High-throughput epitope profiling of antibodies in the plasma of Alzheimer’s disease patients using random peptide microarrays
por: Sim, Kyu-Young, et al.
Publicado: (2019) -
Can hippocampal subfield measures supply information that could be used to improve the diagnosis of Alzheimer’s disease?
por: Kannappan, Balaji, et al.
Publicado: (2022)